Primjeri korištenja Separate tablets na Engleski i njihovi prijevodi na Hrvatskom
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
As separate tablets and adjust the doses before switching to Rasilez HCT.
For patients switching from separate tablets of empagliflozin and metformin.
Twynsta can also be used in place of treatment with telmisartan andamlodipine in patients who are taking both medicines as separate tablets.
Taken as separate tablets, to replace the same doses of the two active substances.
Studies in human volunteers have shown Tandemact tobe bioequivalent to the administration of pioglitazone and glimepiride given as separate tablets.
The patient may need to take separate tablets or capsules before switching to the combination tablet. .
Combivir was shown to be bioequivalent to lamivudine 150 mg andzidovudine 300 mg given as separate tablets, when administered to fasting subjects.
For patients switching from separate tablets of alogliptin and pioglitazone, both alogliptin and pioglitazone should be dosed at the daily dose already being taken.
The company also looked at the way Dutrebis was absorbed in the body in comparison with two separate tablets containing lamivudine and raltegravir.
For a patient who has been taking telmisartan and amlodipine as separate tablets, the dose of Twynsta to be taken depends on the doses of telmisartan and amlodipine that he or she was taking before.
The company provided evidence that the levels of the active substances in the blood were the same in people taking Tandemact andpeople taking the separate tablets.
Three studies of Actos used with metformin as separate tablets were used to support the use of Competact in the same indication.
Clinical studies conducted tosupport the efficacy and safety of Incresync involved the co-administration of alogliptin and pioglitazone as separate tablets.
For patients switching from co-administration of vildagliptin and metformin as separate tablets: Eucreas should be initiated at the dose of vildagliptin and metformin already being taken.
Bioequivalence studies in healthy volunteers have shown Competact to be bioequivalent to the administration of pioglitazone andmetformin given as separate tablets.
Patients previously taking only aliskiren orhydrochlorothiazide may need to take the two substances as separate tablets and adjust the doses before switching to Rasilez HCT.
Patients who experience hypoglycaemia(low blood sugar levels) while taking Tandemact may need to use a lower dose of the medicine orto return to using separate tablets.
The company also looked at the way Triumeq was absorbed in the body in comparison with two separate tablets(dolutegravir and abacavir/lamivudine) containing the three medicines that make it up.
Three additional studies were carried out to show that the active substances were absorbed in the body in the same way when they taken as separate tablets and as Rasilez HCT.
For a patient whose blood pressure is not adequately controlled by amlodipine, separate tablets of amlodipine and telmisartan should be used to adjust the doses before switching to Twynsta.
DuoPlavin is used to prevent problems caused by blood clots and hardening of the arteries, such as a heart attack, in adults who are already taking both clopidogrel andacetylsalicylic acid as separate tablets.
In addition, Incresync can be used to replace separate tablets of alogliptin and pioglitazone in those adult patients aged 18 years and older with type 2 diabetes mellitus already being treated with this combination.
Studies were also carried to show that Twynsta tablets are absorbed in the same way in the body as separate tablets of amlodipine and telmisartan.
Patients switching from separate tablets of dapagliflozin(10 mg total daily dose) and metformin to Ebymect should receive the same daily dose of dapagliflozin and metformin already being taken or the nearest therapeutically appropriate dose of metformin.
It can also beused in patients whose blood pressure is adequately controlled with aliskiren and hydrochlorothiazide taken as separate tablets, to replace the same doses of the two active substances.
Patients receiving telmisartan and amlodipine from separate tablets can instead receive tablets of Onduarp containing the same component doses in one tablet once daily, e.g. to enhance convenience or compliance.
It can also be used in patients whose blood pressure is adequately controlled with aliskiren andhydrochlorothiazide taken as separate tablets, to replace the same doses of the two active substances.
Patients switching from separate tablets of empagliflozin(10 mg or 25 mg total daily dose) and metformin to Synjardy should receive the same daily dose of empagliflozin and metformin already being taken or the nearest therapeutically appropriate dose of metformin.
The company also presented studies showing that the tablet containing all three substances is absorbed in the body in the same way as the separate tablets given concurrently under similar conditions.
For patients switching from separate tablets of alogliptin and metformin(as dual therapy or as part of triple therapy with insulin), both alogliptin and metformin should be dosed at the total daily dose already being taken; the individual dose of alogliptin should be halved as it will be taken twice daily whilst the dosing of metformin should remain unchanged.